Skip to content
Market Tracked raises in 2026$3.41B+$183M this week Rounds76 LatestBlue J$176M Series E Tuesday, November 10

Parambil

Parambil is AI medical record review software for mass tort and complex litigation.

TrueScreen

Certify photos, videos, screenshots, chats, emails and online meetings with forensic methodology. Tamper-proof digital evidence with chain of custody. eIDAS, ISO 27037.

Parambil vs TrueScreen

At a Glance

DetailParambilTrueScreen
CategoryeDiscoveryeDiscovery
Total raised$8MNot disclosed
Rounds tracked2Not disclosed
Latest roundSeed, $6M · Jan 2026Not disclosed
Last valuationNot disclosedNot disclosed
Lead investorsBling Capital, Daybreak VenturesNot disclosed
Built forMid-size firms, BoutiquesNot disclosed
HeadquartersUnited StatesNot disclosed

Funding, Side by Side

Parambil$8M
TrueScreenUndisclosed
Parambil rounds
  1. Jan 2026Seed$6M
  2. Jan 2025Seed$2M
TrueScreen rounds

No public rounds tracked yet.

Our Take

We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.

Quick Answers

Which has raised more, Parambil or TrueScreen?
Parambil has raised $8M in disclosed funding, compared with no disclosed amount for TrueScreen.
What is Parambil best for?
Parambil is AI medical record review software for mass tort and complex litigation.
What is TrueScreen best for?
Certify photos, videos, screenshots, chats, emails and online meetings with forensic methodology. Tamper-proof digital evidence with chain of custody. eIDAS, ISO 27037.

Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.